Eur Rev Med Pharmacol Sci 2022; 26 (17): 6012-6012

DOI: 10.26355/eurrev_202209_29611

Retraction Note: Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma

Y. Chang, Q. Geng, Q. Bao, P. Hu

Department of Radiotherapy, Linyi Cancer Hospital, Linyi, China


The article “Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma, by Y. Chang, Q. Geng, Q. Bao, P. Hu, published in Eur Rev Med Pharmacol Sci 2020; 24 (11): 6409-6416–DOI: 10.26355/eurrev_202006_21539–PMID: 32572938” has been retracted by the authors.

After publication, the article was questioned on PubPeer. Concerns were raised about Figure 3 and the reliability of the published results. The same authors stated that the study was not conducted according to the required standard procedures.

The Publisher apologizes for any inconvenience this may cause

Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma

Free PDF Download

To cite this article

Y. Chang, Q. Geng, Q. Bao, P. Hu
Retraction Note: Salinomycin enhances radiotherapy sensitivity and reduces expressions of BIRC5 and NEIL2 in nasopharyngeal carcinoma

Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 17
Pages: 6012-6012
DOI: 10.26355/eurrev_202209_29611